Sotera Health Company

NasdaqGS SHC

Sotera Health Company EBITDA for the Trailing 12 Months (TTM) ending September 30, 2024: USD 364.39 M

Sotera Health Company EBITDA is USD 364.39 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 880.72% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Sotera Health Company EBITDA for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -46.67 M, a -111.52% change year over year.
  • Sotera Health Company EBITDA for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 405.00 M, a 11.79% change year over year.
  • Sotera Health Company EBITDA for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 362.29 M, a 1.89% change year over year.
  • Sotera Health Company EBITDA for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 355.56 M.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
NasdaqGS: SHC

Sotera Health Company

CEO Mr. Michael B. Petras Jr.
IPO Date Nov. 20, 2020
Location United States
Headquarters 9100 South Hills Boulevard
Employees 3,000
Sector Health Care
Industries
Description

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.

Similar companies

QGEN

Qiagen N.V.

USD 45.57

-0.94%

MEDP

Medpace Holdings, Inc.

USD 330.91

-5.99%

ICLR

ICON Public Limited Company

USD 200.24

-8.14%

XGN

Exagen Inc.

USD 3.00

-3.85%

BNR

Burning Rock Biotech Limited

USD 6.55

-6.69%

SERA

Sera Prognostics, Inc.

USD 6.37

0.63%

FONR

FONAR Corporation

USD 15.16

0.20%

MYGN

Myriad Genetics, Inc.

USD 13.68

-4.20%

NEOG

Neogen Corporation

USD 12.00

-5.06%

ACRS

Aclaris Therapeutics, Inc.

USD 2.50

0.81%

IQV

IQVIA Holdings Inc.

USD 197.96

-3.26%

RDNT

RadNet, Inc.

USD 65.65

-1.41%

StockViz Staff

January 15, 2025

Any question? Send us an email